JP2021512903A5 - - Google Patents

Info

Publication number
JP2021512903A5
JP2021512903A5 JP2020542611A JP2020542611A JP2021512903A5 JP 2021512903 A5 JP2021512903 A5 JP 2021512903A5 JP 2020542611 A JP2020542611 A JP 2020542611A JP 2020542611 A JP2020542611 A JP 2020542611A JP 2021512903 A5 JP2021512903 A5 JP 2021512903A5
Authority
JP
Japan
Prior art keywords
population
cell populations
treg
tcon
populations according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020542611A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021512903A (ja
JP7422667B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/017017 external-priority patent/WO2019157158A2/en
Publication of JP2021512903A publication Critical patent/JP2021512903A/ja
Publication of JP2021512903A5 publication Critical patent/JP2021512903A5/ja
Priority to JP2024004747A priority Critical patent/JP7652949B2/ja
Application granted granted Critical
Publication of JP7422667B2 publication Critical patent/JP7422667B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020542611A 2018-02-08 2019-02-07 同種造血幹細胞移植のための方法 Active JP7422667B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024004747A JP7652949B2 (ja) 2018-02-08 2024-01-16 同種造血幹細胞移植のための方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862628015P 2018-02-08 2018-02-08
US62/628,015 2018-02-08
PCT/US2019/017017 WO2019157158A2 (en) 2018-02-08 2019-02-07 Methods for allogenic hematopoietic stem cell transplantation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024004747A Division JP7652949B2 (ja) 2018-02-08 2024-01-16 同種造血幹細胞移植のための方法

Publications (3)

Publication Number Publication Date
JP2021512903A JP2021512903A (ja) 2021-05-20
JP2021512903A5 true JP2021512903A5 (cg-RX-API-DMAC7.html) 2022-02-15
JP7422667B2 JP7422667B2 (ja) 2024-01-26

Family

ID=67549051

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020542611A Active JP7422667B2 (ja) 2018-02-08 2019-02-07 同種造血幹細胞移植のための方法
JP2024004747A Active JP7652949B2 (ja) 2018-02-08 2024-01-16 同種造血幹細胞移植のための方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024004747A Active JP7652949B2 (ja) 2018-02-08 2024-01-16 同種造血幹細胞移植のための方法

Country Status (10)

Country Link
US (5) US11952588B2 (cg-RX-API-DMAC7.html)
EP (2) EP4529957A3 (cg-RX-API-DMAC7.html)
JP (2) JP7422667B2 (cg-RX-API-DMAC7.html)
CN (1) CN111971052B (cg-RX-API-DMAC7.html)
AU (2) AU2019218792A1 (cg-RX-API-DMAC7.html)
CA (1) CA3090175A1 (cg-RX-API-DMAC7.html)
DK (1) DK3749334T3 (cg-RX-API-DMAC7.html)
ES (1) ES3012854T3 (cg-RX-API-DMAC7.html)
PL (1) PL3749334T3 (cg-RX-API-DMAC7.html)
WO (1) WO2019157158A2 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES3012854T3 (en) 2018-02-08 2025-04-10 Univ Leland Stanford Junior Allogenic hematopoietic stem cell transplantation
US12492254B2 (en) 2018-02-23 2025-12-09 H. Lee Moffitt Cancer Center and Research Intitute. Inc. CD83-binding chimeric antigen receptors
EP4013447A4 (en) * 2019-08-16 2024-05-29 H. Lee Moffitt Cancer Center & Research Institute, Inc. T CELLS EXPRESSING A CHIMERIC ANTI-CD83 ANTIGEN RECEPTOR
CN117177748A (zh) * 2020-11-04 2023-12-05 浩康生物系统公司 用于异基因造血干细胞移植的方法
AU2021373797A1 (en) * 2020-11-04 2023-06-08 Orca Biosystems, Inc. Methods for allogeneic hematopoietic stem cell transplantation
WO2022204523A1 (en) * 2021-03-25 2022-09-29 Cellenkos, Inc. Populations of enriched regulatory t cells and methods for producing same
EP4426318A4 (en) * 2021-11-04 2025-11-19 Orca Biosystems Inc THERAPEUTIC COMPOSITIONS AND TRANSPLANTATION PROCESSES OF ALLOGENEIC HEMATOPOIETIC CELLS
AU2023252879A1 (en) * 2022-04-15 2024-11-21 Orca Biosystems, Inc. Methods for allogeneic hematopoietic stem cell transplantation
EP4611778A4 (en) * 2022-11-03 2026-07-15 Orca Biosystems Inc COMPOSITION AND METHODS FOR HEMATOPOIETIC STEM CELL TRANSPLANTS
CN121693336A (zh) * 2023-05-09 2026-03-17 麦克莱恩医院公司 帕金森病细胞疗法中自体treg和mda细胞的纹状体内共移植

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL107483A0 (en) 1993-11-03 1994-02-27 Yeda Res & Dev Bone marrow transplantation
EP1461087A1 (en) * 2001-12-06 2004-09-29 Institut National De La Sante Et De La Recherche Medicale (Inserm) Use of cd34+ hematopoietic progenitor cells for the treatment of cns disorders
JP4988172B2 (ja) 2005-06-24 2012-08-01 株式会社日立製作所 固体酸化物形燃料電池発電システム
EP2514315A3 (en) 2005-08-24 2012-11-07 Yeda Research and Development Co. Ltd. Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
US11291686B2 (en) 2008-05-30 2022-04-05 University Of Louisville Research Foundation, Inc. Human facilitating cells
US8632768B2 (en) 2008-05-30 2014-01-21 University Of Louisville Research Foundation, Inc. Human facilitating cells
WO2010022341A1 (en) 2008-08-21 2010-02-25 The United State Of America, As Represented By The Secretary, Department Of Health And Human Services Methods of enriching and using regulatory t cells
US8772028B2 (en) 2008-11-07 2014-07-08 Sunnybrook Health Sciences Centre CD34+CD7+CD5+CD1a-human progenitor T-cells produced in vitro and methods of using
AU2010278702C1 (en) * 2009-07-31 2016-07-14 Forsyth Dental Infirmary For Children Programming of cells for tolerogenic therapies
EP2378287A1 (en) 2010-04-15 2011-10-19 TXCell New method for isolating Tr1 cells
RU2657758C2 (ru) 2011-12-22 2018-06-15 Иеда Рисеч Энд Девелопмент Ко. Лтд. Комбинированная терапия для стабильного и долговременного приживления трансплантата
WO2013130499A1 (en) 2012-02-29 2013-09-06 University Of Virginia Patent Foundation Compositions and methods for cxcr4 signaling and umbilical cord blood stem cell engraftment
WO2013173076A1 (en) 2012-05-04 2013-11-21 University Of Southern California Methods and compositions for generating and using allogeneic suppressor cells
WO2014165581A1 (en) 2013-04-02 2014-10-09 New York University Gpr15-mediated homing and uses thereof
US11850592B2 (en) 2017-11-13 2023-12-26 Owl biomedical, Inc. Particle manipulation system with multisort valve
US20160250258A1 (en) * 2013-10-31 2016-09-01 Fred Hutchinson Cancer Research Center Modified hematopoietic stem/progenitor and non-t effector cells, and uses thereof
WO2015171691A2 (en) 2014-05-06 2015-11-12 Scholar Rock, Inc. Compositions and methods for growth factor modulation
RU2751362C2 (ru) 2014-12-29 2021-07-13 Новартис Аг Способы получения экспрессирующих химерный антигенный рецептор клеток
PL3265123T3 (pl) 2015-03-03 2023-03-13 Kymab Limited Przeciwciała, zastosowania i sposoby
WO2017023753A1 (en) 2015-07-31 2017-02-09 University Of Florida Research Foundation, Inc. Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer
JP7105188B2 (ja) 2015-08-25 2022-07-22 ザ・ユー・エイ・ビー・リサーチ・フアンデーシヨン 幹細胞移植方法
US20180251731A1 (en) 2015-09-07 2018-09-06 INSERM (Institute National de la Santé et de la Recherche Médicale) Subpopulation of cd8+cd45rclow tregs and uses thereof
KR20180086204A (ko) 2015-11-05 2018-07-30 글리코스템 떼라퓨틱스 비.브이. 면역치료법에 사용하기 위한 조성물
US20190032013A1 (en) 2016-01-29 2019-01-31 Tract Therapeutics, Inc. Immune cell selection, expansion, and use
US10383895B2 (en) 2016-02-18 2019-08-20 Viera Bioscience, Inc. Stimulation of therapeutic angiogenesis by T regulatory cells
EP3430052A2 (en) 2016-03-14 2019-01-23 Millennium Pharmaceuticals, Inc. Method of preventing graft versus host disease
WO2018106610A1 (en) 2016-12-05 2018-06-14 The Regents Of The University Of California Immunomagnetic bead-based method to enrich stem cells from whole hematopoietic tissue
CN110913690A (zh) 2017-03-14 2020-03-24 朱诺治疗学股份有限公司 用于低温储存的方法
CN118662615A (zh) 2017-03-15 2024-09-20 浩康生物系统公司 用于造血干细胞移植的组合物和方法
US11662343B2 (en) 2017-04-07 2023-05-30 The Council Of The Queensland Institute Of Medical Research Cellular populations and uses thereof
EP3450981A1 (en) 2017-08-28 2019-03-06 Trizell GmbH Btnl8 as a marker for tregs
ES3012854T3 (en) 2018-02-08 2025-04-10 Univ Leland Stanford Junior Allogenic hematopoietic stem cell transplantation
EP3765044A4 (en) 2018-03-12 2021-12-08 Medeor Therapeutics, Inc. TREATMENT METHODS FOR NON-CANCERIOUS DISORDERS USING HEMATOPOIETIC CELLS
US10881692B2 (en) 2018-04-05 2021-01-05 Medeor Therapeutics, Inc. Compositions for establishing mixed chimerism and methods of manufacture thereof
US10842821B2 (en) 2018-04-05 2020-11-24 Medeor Therapeutics, Inc. Cellular compositions derived from prior organ donors and methods of manufacture and use thereof
US20220305057A1 (en) 2019-06-06 2022-09-29 Medeor Therapeutics, Inc. Methods of making cellular products by post- mortem mobilization and harvesting of hematopoietic cells
AU2021373797A1 (en) 2020-11-04 2023-06-08 Orca Biosystems, Inc. Methods for allogeneic hematopoietic stem cell transplantation

Similar Documents

Publication Publication Date Title
Chang et al. Strategies for enhancing and preserving anti-leukemia effects without aggravating graft-versus-host disease
Svobodova et al. The role of mouse mesenchymal stem cells in differentiation of naive T-cells into anti-inflammatory regulatory T-cell or proinflammatory helper T-cell 17 population
Sensebe et al. Mesenchymal stem cells for clinical application
JP6266726B2 (ja) 放射線照射または化学物質による傷害を治療するための方法
Tolosa et al. Mankind’s first natural stem cell transplant
Aversa et al. The evolution of T cell depleted haploidentical transplantation
Gao et al. The immunosuppressive properties of non-cultured dermal-derived mesenchymal stromal cells and the control of graft-versus-host disease
CN115137752A (zh) 用于干细胞移植的方法
Bader et al. Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells
CN115137753A (zh) 来自胎盘的自然杀伤细胞
Couban et al. The case for plerixafor to replace filgrastim as the optimal agent to mobilize peripheral blood donors for allogeneic hematopoietic cell transplantation
Ukrainskaya et al. Haploidentical donor-derived memory CAR T cells: first in human experience and in vitro correlative study
Locatelli et al. Strategies to optimize the outcome of children given T-cell depleted HLA-haploidentical hematopoietic stem cell transplantation
US20150374755A1 (en) Treated Cells and Therapeutic Uses
US20150174173A1 (en) Stem cell treatment for radiation exposure
US20200306302A1 (en) Treating and inhibiting leukemia with nk-92 cells
JP6401445B2 (ja) 造血幹細胞移植用の組合せ細胞製剤および生着促進剤並びにこれらの製造方法
Lázár et al. Difficulties of Mobilization and Harvesting of Hematopoietic Stem Cells in Heavily Pre-Treated Patients
Kondo et al. Guidelines on cell therapy
Baiamonte et al. Hematopoietic stem cell mobilization for gene therapy: the combination of G-CSF+ plerixafor in patients with beta-thalassemia major provides high yields of CD34+ cells with primitive signatures
Sedlmayr et al. Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia
Grazia et al. Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow‐derived progenitor cells
EP4680253A1 (en) Dendritic cell populations that inhibit gvhd
Hong et al. Feasibility of second hematopoietic stem cell transplantation using reduced-intensity conditioning with fludarabine and melphalan after a failed autologous hematopoietic stem cell transplantation
CN121610450A (zh) 一种活性高靶向性强的nk细胞及其制备方法和应用